SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-028015
Filing Date
2022-08-04
Accepted
2022-08-04 16:16:43
Documents
14
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-8k_20220804.htm   iXBRL 8-K 35342
2 EX-99.1 drrx-ex991_6.htm EX-99.1 321761
  Complete submission text file 0001564590-22-028015.txt   535084

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20220804.xsd EX-101.SCH 6307
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20220804_def.xml EX-101.DEF 13910
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20220804_lab.xml EX-101.LAB 23731
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20220804_pre.xml EX-101.PRE 14621
8 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8k_20220804_htm.xml XML 5378
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 221136803
SIC: 2834 Pharmaceutical Preparations